Efficacy and safety of ibuprofen in infants aged between 3 and 6 months
Ibuprofen is a non-steroidal anti-inflammatory drug frequently administered to children of various ages for relief of fever and pain and is approved as an over-the-counter medication in many countries worldwide. Although there are extensive data on its efficacy and safety in children and adults, the...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
17 May 2017
|
| In: |
Pediatric drugs
Year: 2017, Volume: 19, Issue: 4, Pages: 277-290 |
| ISSN: | 1179-2019 |
| DOI: | 10.1007/s40272-017-0235-3 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1007/s40272-017-0235-3 Verlag, Volltext: https://link.springer.com/article/10.1007/s40272-017-0235-3 
|
| Author Notes: | Victoria C. Ziesenitz, Andreas Zutter, Thomas O. Erb, Johannes N. van den Anker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1580153402 | ||
| 003 | DE-627 | ||
| 005 | 20230427065647.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180817s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40272-017-0235-3 |2 doi | |
| 035 | |a (DE-627)1580153402 | ||
| 035 | |a (DE-576)510153402 | ||
| 035 | |a (DE-599)BSZ510153402 | ||
| 035 | |a (OCoLC)1341017000 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ziesenitz, Victoria C. |d 1985- |e VerfasserIn |0 (DE-588)1036795640 |0 (DE-627)751696099 |0 (DE-576)386865132 |4 aut | |
| 245 | 1 | 0 | |a Efficacy and safety of ibuprofen in infants aged between 3 and 6 months |c Victoria C. Ziesenitz, Andreas Zutter, Thomas O. Erb, Johannes N. van den Anker |
| 264 | 1 | |c 17 May 2017 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.08.2018 | ||
| 520 | |a Ibuprofen is a non-steroidal anti-inflammatory drug frequently administered to children of various ages for relief of fever and pain and is approved as an over-the-counter medication in many countries worldwide. Although there are extensive data on its efficacy and safety in children and adults, there are divergent dosing recommendations for analgesia and treatment of fever in infants, especially in the age group between 3 and 6 months of age. In this article, we have assessed the safety and efficacy of ibuprofen use in infants in an attempt to find the optimal method of pain and fever management in this specific age group. Based on the current evidence, short-term use of ibuprofen is considered safe in infants older than 3 months of age having a body weight above 5-6 kg when special attention is given to the hydration of the patient. Ibuprofen should be prescribed based on body weight using a dose of 5-10 mg/kg. This dose can be administered 3-4 times a day resulting in a maximum total daily dose of 30-40 mg/kg. The rectal route has been shown to be less reliable because of erratic absorption, especially in young infants. Since most efficacy and safety data have been derived from trials in infants with fever, future studies should focus on the efficacy of ibuprofen in young infants with pain. | ||
| 773 | 0 | 8 | |i Enthalten in |t Pediatric drugs |d Berlin [u.a.] : Springer, 1999 |g 19(2017), 4, Seite 277-290 |h Online-Ressource |w (DE-627)327644214 |w (DE-600)2043681-6 |w (DE-576)273880802 |x 1179-2019 |7 nnas |a Efficacy and safety of ibuprofen in infants aged between 3 and 6 months |
| 773 | 1 | 8 | |g volume:19 |g year:2017 |g number:4 |g pages:277-290 |g extent:14 |a Efficacy and safety of ibuprofen in infants aged between 3 and 6 months |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40272-017-0235-3 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s40272-017-0235-3 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180817 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1036795640 |a Ziesenitz, Victoria C. |m 1036795640:Ziesenitz, Victoria C. |d 910000 |d 910500 |e 910000PZ1036795640 |e 910500PZ1036795640 |k 0/910000/ |k 1/910000/910500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1580153402 |e 3022538200 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1580153402"],"doi":["10.1007/s40272-017-0235-3"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"17 May 2017"}],"name":{"displayForm":["Victoria C. Ziesenitz, Andreas Zutter, Thomas O. Erb, Johannes N. van den Anker"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Berlin [u.a.] ; Auckland [u.a.]","publisher":"Springer ; Adis Intern.","dateIssuedKey":"1999","dateIssuedDisp":"1999-"}],"id":{"issn":["1179-2019"],"zdb":["2043681-6"],"eki":["327644214"]},"note":["Gesehen am 23.04.14"],"disp":"Efficacy and safety of ibuprofen in infants aged between 3 and 6 monthsPediatric drugs","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"327644214","language":["eng"],"pubHistory":["1.1999 -"],"titleAlt":[{"title":"Paediatric drugs"}],"part":{"pages":"277-290","issue":"4","year":"2017","extent":"14","volume":"19","text":"19(2017), 4, Seite 277-290"},"title":[{"title_sort":"Pediatric drugs","title":"Pediatric drugs","subtitle":"evaluations of drug therapy and disease management in children"}]}],"physDesc":[{"extent":"14 S."}],"title":[{"title_sort":"Efficacy and safety of ibuprofen in infants aged between 3 and 6 months","title":"Efficacy and safety of ibuprofen in infants aged between 3 and 6 months"}],"person":[{"family":"Ziesenitz","given":"Victoria C.","display":"Ziesenitz, Victoria C.","roleDisplay":"VerfasserIn","role":"aut"}],"language":["eng"],"recId":"1580153402","note":["Gesehen am 17.08.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a ZIESENITZVEFFICACYAN1720 | ||